Appco Pharma LLC (Appco) is voluntarily recalling all quantities and lots, within expiry, of Ranitidine Hydrochloride Capsules to the Consumer level. Ranitidine Hydrochloride Capsules are being ...

A new nationwide recall has been issued for a generic version of the heartburn and ulcer drug Zantac due to the potential presence of an impurity that could cause cancer. It's the fourth recall for ...

After a quiet December, recalls of ranitidine — brand name: Zantac — resumed Tuesday with Appco Pharma pulling all quantities and lots of 150mg and 300mg ranitidine hydrochloride capsules. The problem ...

WASHINGTON — More common heartburn medications have been recalled due to the presence of an impurity that might cause cancer. Denton Pharma Inc. this week recalled several batches of ranitidine ...

More generic versions of Zantac are being pulled from pharmacy shelves after officials discovered low levels of a probable carcinogen in the heartburn drug. The Food and Drug Administration this week ...

Both Appco Pharma and Denton Pharma are voluntarily recalling all unexpired lots of their ranitidine products after finding they contained levels of a human carcinogen. The recalls are the latest in a ...

Voluntarily recalling all quantities and lots, within expiry, of Ranitidine Hydrochloride Capsules in the US to the consumer level. Ranitidine Hydrochloride Capsules are being recalled because of ...

(WAFB) - Several medications used to treat heartburn and acid reflux are being recalled after manufacturers detected trace amounts of the same probable cancer-causing impurity that prompted earlier ...

(HealthDay)—The U.S. Food and Drug Administration is adding to a list of recalled lots of popular heartburn medications—including generic forms of Zantac—because the pills might contain small amounts ...

People who took ranitidine (Zantac) for at least a month were no more likely to develop cancer than people who used other histamine-2 receptor antagonists (H2RAs), according to a retrospective ...

Denton Pharma Inc. this week recalled several batches of ranitidine tablets. The recall impacts all unexpired lots of 150 mg and 300 mg tablets. The pills were distributed to Northwind Pharmaceuticals ...